Table 2.
Tumor criteria of breast cancer patients.
| Parameters | Breast cancer patients N= 100 (%) |
|---|---|
| Pathology | |
| IDC | 80 (80%) |
| ILC | 20 (20%) |
| Tumor size | |
| T1 | 19 (19%) |
| T2-T4 | 81 (81%) |
| Lymph nodes | |
| N0 | 34 (34%) |
| N1-N3 | 66 (66%) |
| Stage | |
| I-II | 43 (43%) |
| III-IV | 57 (57%) |
| Grade | |
| 2 | 83 (83%) |
| 3 | 17 (17%) |
| Immunohistochemical subtypes | |
| Luminal A (ER+/PR+/HER2-) | 31 (31%) |
| Luminal B (ER+/PR+/HER2-/+) | 20 (20%) |
| HER2-enriched (ER-/PR-/HER2+) | 49 (49%) |
IDC: Invasive ductal carcinoma, ILC: Invasive lobular carcinoma, HER2Neu: Human epidermal growth factor2, ER: Estrogen Receptor, PR: Progesterone Receptor.